New Insights in Lung Involvement Secondary to Autoimmune Diseases
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: closed (20 August 2024) | Viewed by 7128
Special Issue Editors
Interests: interstitial pneumonia with autoimmune features; IPAF; interstitial lung diseases associated with systemic autoimmune diseases
Interests: idiopathic inflammatory myopathies; antisynthetase syndrome
Interests: connective tissues diseases; interstitial lung disease associated to connective tissue diseases; disease activity; nailfold capillaroscopy
Special Issue Information
Dear Colleagues,
Respiratory failure is among the main causes of mortality in many Systemic Autoimmune Diseases (SAD), including Rheumatoid Arthritis (RA), Vasculitides and Connective Tissue Diseases.
Lung involvement in the context of SAD typically results in Interstitial Lung Disease (ILD), however obstructive conditions due to small airways involvement are not uncommon.
ILD may represent the first manifestation of SAD, dominating the clinical picture compared to more nuanced non-respiratory signs and symptoms. In these cases, proper classification of the underlying SAD becomes a true challenge and may be subjected to variations during follow-up (e.g., Interstitial Pneumonia with autoimmune features progressing to a specific SAD).
Diagnosis and management of SAD-related lung involvement often requires a multidisciplinary approach involving pulmonologists and rheumatologists, which is not always feasible in routine clinical practice.
This Special Issue aims to collect the most recent findings regarding diagnosis and management of patients affected by SAD with lung involvement. We believe that this focused approach will significantly contribute to current knowledge on this topic. Another purpose of this Special Issue is to stimulate the scientific debate and a closer collaboration between pulmonologists and rheumatologists aimed at a mutual sharing of competences.
In this Special Issue, original research articles, brief reports of original data and reviews are welcome. Research areas may include (but should not be limited to) the following:
- Diagnostic approach to SAD patients with lung involvement;
- Imaging techniques for assessment of SAD-related lung involvement, including application of artificial intelligence to HRCT analysis;
- Risk factors for lung involvement in SAD patients;
- Prognosis of SAD with lung involvement;
- Pathogenic mechanisms underlying lung involvement in SAD;
- Multidisciplinary evaluation of SAD patients with lung involvement;
- Therapeutic strategies for SAD-related lung involvement.
We look forward to receiving your contributions.
Dr. Gianluca Sambataro
Dr. Giovanni Zanframundo
Dr. Domenico Sambataro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- interstitial lung disease
- interstitial pneumonia with autoimmune features
- antisynthetase syndrome
- rheumatoid arthritis
- Sjogren’s syndrome
- systemic sclerosis
- idiopathic inflammatory myopathy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.